SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-074631
Filing Date
2021-06-01
Accepted
2021-06-01 08:05:10
Documents
3
Period of Report
2021-05-28
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2118028d1_8k.htm 8-K 26408
2 EXHIBIT 99.1 tm2118028d1_ex99-1.htm EX-99.1 10453
3 GRAPHIC image_001.jpg GRAPHIC 4121
  Complete submission text file 0001104659-21-074631.txt   43849
Mailing Address 250 WEST 55TH STREET, SUITE 13D NEW YORK NY 10019
Business Address 250 WEST 55TH STREET, SUITE 13D NEW YORK NY 10019 (212) 710-5220
Eucrates Biomedical Acquisition Corp. (Filer) CIK: 0001822929 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D8
Type: 8-K | Act: 34 | File No.: 001-39650 | Film No.: 21983124
SIC: 6770 Blank Checks